Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Journal: Nature

Published: 2018-09-26

DOI: 10.1038/s41586-018-0531-2

Affiliations: 19

Authors: 36

Go to article
Institutions FC
Laboratory of Molecular Immunology, The Rockefeller University, United States of America (USA) 0.46
Innere Medizin I - Onkologie, Hämatologie, Klinische Infektiologie, Klinische Immunologie, Hämostaseologie, Internistische Intensivmedizin, Germany 0.12
Division of Biology and Biological Engineering (BBE), Caltech, United States of America (USA) 0.06
DZIF Partner Site Bonn-Cologne, Germany 0.05
Institute of Virology, UoC, Germany 0.04
Laboratory of Experimental Immunology, UoC, Germany 0.04
Department of Computer Science, Uni Tübingen, Germany 0.03
Duke Human Vaccine Institute (DHVI), United States of America (USA) 0.03
Praxis am Ebertplatz, Germany 0.03
Division of Infectious Diseases, Cornell University, United States of America (USA) 0.03
Center for Virology and Vaccine Research, BIDMC, United States of America (USA) 0.03
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.03
The Rockefeller University, United States of America (USA) 0.01
Duke Department of Surgery, United States of America (USA) 0.01
Duke Department of Immunology, United States of America (USA) 0.01
Duke Department of Molecular Genetics and Microbiology, United States of America (USA) 0.01
Faculty of Medicine, Uni Tübingen, Germany 0.01
DZIF Partner Site Tübingen, Germany 0.01
Max Planck Institute for Informatics (MPI-INF), Germany 0.01

Return